SARS-CoV-2 Infection-Induced Alterations in ADAR Editing Patterns Differ Between Patients Who Developed Critical Compared to Non-Critical COVID-19
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27156809 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Aiswarya Mukundan Nair und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Kent State University, Kent, OH 44242, USA. Hauptthemen laut MEDLINE: Adenosine Deaminase, COVID-19, RNA Editing, RNA-Binding Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
COVID-19, caused by the SARS-CoV-2 virus, has a wide spectrum of clinical presentations even among individuals with similar demographics. Disease severity has been linked with viral-mediated expression of interferons and interferon-stimulated genes. Among the interferon-stimulated genes are members of adenosine deaminases acting on the RNA (ADAR) family that contribute to transcriptome diversity and modulate immune response. Previous studies identified altered ADAR expression and editing patterns during SARS-CoV-2 infection, although it remains unclear whether ADAR expression and activity differ between patients with varying severities of COVID-19. We used whole-blood transcriptomes from individuals with critical or non-critical COVID-19 and matched for age, sex, and presence of comorbidities. Results show differential expression of numerous genes, including those involved in neutrophil degranulation, and upregulation of ADAR1 and its isoform ADARp110 in patients with critical COVID-19. We identified severity-specific editing events, including nonsynonymous edits, within distinct biological pathways. Differentially edited sites—that could serve as molecular markers for COVID-19 severity—were found within genes enriched in signal transduction, RNA and protein metabolism, and inflammatory pathways. Our results demonstrate differences in expression and editing patterns of ADARs between critical and non-critical patients, supporting a potential role of ADAR editing in COVID-19 pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Kent State University, Kent, OH 44242, USA.
- Brain Health Research Institute, Kent State University, Kent, OH 44242, USA.
- Healthy Communities Research Institute, Kent State University, Kent, OH 44242, USA.
ORCID-Profile: Helen Piontkivska
Zitieren
APA
Mukundan Nair, A., & Piontkivska, H. (2026). SARS-CoV-2 Infection-Induced Alterations in ADAR Editing Patterns Differ Between Patients Who Developed Critical Compared to Non-Critical COVID-19. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27156809
Vancouver
Mukundan Nair A, Piontkivska H. SARS-CoV-2 Infection-Induced Alterations in ADAR Editing Patterns Differ Between Patients Who Developed Critical Compared to Non-Critical COVID-19. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27156809
BibTeX
@article{MukundanNair2026,
author = {Mukundan Nair, Aiswarya and Piontkivska, Helen},
title = {SARS-CoV-2 Infection-Induced Alterations in ADAR Editing Patterns Differ Between Patients Who Developed Critical Compared to Non-Critical COVID-19},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27156809}
}
EUVIMED